Metabolic disease remission after Roux-en-Y gastric bypass depends on preoperative disease severity: use of a new objective metabolic scoring system.

ABSTRACT:

Background

Severity stratification and longitudinal evaluation of metabolic conditions in response to Roux-en-Y gastric bypass (RYGB) are not standardized. Our Assessment of Obesity-related Metabolic Comorbidities (AOMC) scoring tool combines pharmacotherapy and biochemical data to objectively define type 2 diabetes (T2D), hypertension (HTN), and dyslipidemia (DYS) severity. We previously showed that AOMC more accurately describes disease severity than clinical history alone.

Objectives

We aimed to show that AOMC more precisely and reproducibly measures metabolic disease response to RYGB and preoperative disease severity influences remission rates.

Setting

University hospital, United States.

Methods

AOMC scores for T2D, DYS, and HTN were calculated preoperative

SUBMITTER: Wang A 

PROVIDER: S-EPMC11651301 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature